US Patent 10150797 Respiratory syncytial virus (RSV) vaccine
Patent 10150797 was granted and assigned to CureVac on December, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10150797 Respiratory syncytial virus (RSV) vaccine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.